The partnership will focus on hepatic fibrosis, a key factor in the diagnosis and treatment of liver disease; currently, hepatic fibrosis is most commonly diagnosed using liver biopsy. GE will contribute its MR elastography technology to generate a liver stiffness map for research and development work Takeda is conducting on liver disease. The firms hope to develop therapeutic drugs and new diagnostic technologies for liver diseases via their collaboration.
Terms of the deal are not being disclosed.
Copyright © 2014 AuntMinnieEurope.com